Biopharmaceutical leader in the development of treatments for rare diseases
H.R.5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Educated staff about access to therapies for rare diseases in Medicaid.

March 2016 CMS proposed rule implementing a new Part B drug payment model. Education about the value of innovative new medicines.

H.R. 34: 21st Century Cures Act as it relates to S. 1878: To extend the pediatric priority review voucher program.

S. 3056: CREATES Act of 2016.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX